Use of octogenarian donors for liver transplantation: A survival analysis

American Journal of Transplantation

Volumn 14, Issue 9, 2014, Pages 2062-2071

  Ghinolfi, D ^a   Marti, J ^b   De Simone, P ^a   Lai, Q ^a   Pezzati, D ^a   Coletti, L ^a   Tartaglia, D ^a   Catalano, G ^a   Tincani, G ^a   Carrai, P ^a   Campani, D ^a   Miccoli, M ^c   Biancofiore, G ^a   Filipponi, F ^a  

^a UNIVERSITY HOSPITAL OF PISA   (Italy)

^b UNIVERSITY OF BARCELONA   (Spain)

^c UNIVERSITY OF PISA   (Italy)

Author keywords

Clinical research practice; donors and donation: deceased; donors and donation: extended criteria; liver disease; liver transplantation hepatology; organ procurement and allocation

Indexed keywords

AZATHIOPRINE; CALCINEURIN INHIBITOR; CYCLOSPORIN; HYPERTENSIVE FACTOR; MYCOPHENOLIC ACID; STEROID; TACROLIMUS;

ADULT; AGED; ARTICLE; BILE DUCT DISEASE; BLOOD GROUP ABO SYSTEM; CAVA VEIN OBSTRUCTION; COMMON BILE DUCT NECROSIS; COMMON BILE DUCT STONE; FEMALE; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT SURVIVAL; HEPATIC ARTERY THROMBOSIS; HEPATITIS B; HEPATITIS C; HUMAN; LIVER ABSCESS; LIVER CELL CARCINOMA; LIVER GRAFT REJECTION; LIVER HEMATOMA; LIVER RESECTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OPERATIVE BLOOD LOSS; ORGAN DONOR; PORTAL VEIN THROMBOSIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; DONOR; GRAFT REJECTION; SURVIVAL; VERY ELDERLY;

AGED; AGED, 80 AND OVER; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; LIVER TRANSPLANTATION; MALE; SURVIVAL ANALYSIS; TISSUE DONORS;

EID: 84906264505     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.12843     Document Type: Article

References (43)

1. Busuttil RW, Tanaka K., The utility of marginal donors in liver transplantation. Liver Transplant 2003; 9: 651-663.
2. Gordon Burroughs S, Busuttil RW., Optimal utilization of extended hepatic grafts. Surg Today 2009; 39: 746-751.
3. Pirenne J, Monbaliu D, Van Gelder F, et al. Liver transplantation using livers from septuagenarian and octogenarian donors: An underused strategy to reduce mortality on the waiting list. Transplant Proc 2005; 37: 1180-1181.
4. Ploeg RJ, D'Alessandro AM, Knechtle SJ, et al. Risk factors for primary dysfunction after liver transplantation-A multivariate analysis. Transplantation 1993; 55: 807-813.
5. Cameron AM, Ghobrial RM, Yersiz H, et al. Utilization of donor grafts with extended criteria. A single center experience in over 1000 liver transplants. Ann Surg 2006; 243: 748-755.
6. Nickkholgh A, Weitz J, Encke J, et al. Utilization of extended donor criteria in liver transplantation: A comprehensive review of the literature. Nephrol Dial Transplant 2007; 22 (Suppl 8): 29-36.
7. Berenguer M, Prieto M, San Juan F, et al. Contribution of donor age to the recent decrease in patient survival among HCV infected liver transplant recipients. Hepatology 2002; 36: 201-210.
8. Feng S, Goodrich NP, Bragg-Gresham JL, et al. Characteristics associated with liver graft failure: The concept of a donor risk index. Am J Transplant 2006; 6: 783-790.
9. UNOS Data. Available at: http://optn.transplant.hrsa.gov/latestData/ rptData.asp. Accessed September 24, 2013.
10. Cescon M, Grazi GL, Ercolani G, et al. Long term survival of recipients of liver grafts from donors older than 80 years: Is it achievable ? Liver Transpl 2003; 9: 1174-1180.
11. Anderson CD, Vachhrajani N, Doyle M, et al. Advanced donor age alone does not affect patient or graft survival after liver transplantation. J Am Coll Surg 2008; 207: 847-852.
12. Darius T, Monbaliu D, Jochmans I, et al. Septuagenarian and octogenarian donors provide excellent liver grafts for transplantation. Transplant Proc 2012; 44: 2861-2867.
13. Nanni Costa A, Grossi P, Gianelli Castiglione A, Grigioni F, Italian Transplant Research Network. Quality and safety in the Italian donor evaluation process. Transplantation 2008; 85 (8 Suppl): S52-S56.
14. Ishak K, Baptista A, Bianchi L, et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995; 22: 696-699.
15. Dindo D, Demartines N, Clavien PA., Classification of surgical complications: A new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004; 240: 205-213.
16. Demetris A, Adams D, Bellamy C, et al. Update of the International Banff Schema for Liver Allograft Rejection: Working recommendations for histopathological staging and reporting of chronic rejection. Hepatology 2000; 31: 792-799.
17. Urbani L, Mazzoni A, Colombatto P, et al. A novel immunosuppressive strategy combined with preemptive antiviral therapy improves the eighteen-month mortality in HCV recipients transplanted with aged livers. Transplantation 2008; 86: 1666-1671.
18. Boggi U, Vistoli F, Del Chiaro M, et al. A simplified technique for the en bloc procurement of abdominal organs that is suitable for pancreas and small-bowel transplantation. Surgery 2004; 135: 629-641.
19. Freeman RB, Gish RG, Harper A, et al. Model for end-stage liver disease (MELD) exception guidelines: Results and recommendations from the MELD exception study group and conference (MES-SAGE) for the approval of patients who need liver transplantation with diseases not considered by the standard MELD formula. Liver Transpl 2006; 12: S128-S136.
20. Briceno J, Solorzano G, Pera C., A proposal for scoring marginal liver grafts. Transpl Int 2000; 13 (Suppl): 249-252.
21. Tekin K, Imber CJ, Atli M, et al. A simple scoring system to evaluate the effects of cold ischemia on marginal liver donors. Transplantation 2004; 77: 411-416.
22. Busuttil RW, Farmer DG, Yersiz H, et al. Analysis of long term outcomes of 3200 liver transplantation over two decades: A single center experience. Ann Surg 2005; 241: 905-916.
23. Moore DE, Feurer ID, Speroff T, et al. Impact of donor, technical and recipient risk factors on survival and quality of life after liver transplantation. Arch Surg 2005; 140: 273-277.
24. Gastaca M, Valdivieso A, Pijoan J, et al. Donors older than 70 years in liver transplantation. Transplant Proc 2005; 37: 3851-3854.
25. Zapletal C, Faust D, Wullstein C, et al. Does the liver ever age? Results of liver transplantation with donors above 80 years of age. Transplant Proc 2005; 37: 1182-1185.
26. Cescon M, Grazi GL, Cucchetti A, et al. Improving the outcome of liver transplantation with very old donors with updated selection and management criteria. Liver Transpl 2008; 14: 672-679.
27. Segev DL, Maley WR, Simpkins CE, et al. Minimizing risk associated with elderly donors by matching to preferred recipients. Hepatology 2007; 46: 1907-1918.
28. Gruttadauria S, Vizzini G, Biondo D, et al. Critical use of extended criteria donor liver grafts in adult to adult whole liver transplantation: A single center experience. Liver Transpl 2008; 14: 220-227.
29. Filipponi F, De Simone P, Rossi E., The Tuscany Model of a regional transplantation service authority: Organizzazione Toscana Trapianti. Transplant Proc 2007; 39: 2953-2960.
30. Scientific Registry of Transplant Recipients. Available at: http://www.srtr.org/annual-Reports/2011/204-don-gender-dc.aspx?o=3&g= 4&c=2. Accessed February 12, 2014.
31. Lai JC, Feng S, Roberts JP, Terrault NA., Gender differences in liver donor quality are predictive of graft loss. Am J Transplant 2011; 11: 296-302.
32. Murugan R, Sileanu F, Wahed AS, Al-Khafaji A, Singbartl K, Kellum JA., Sex differences in deceased donor organ transplantation rates in the United States. Transplantation 2011; 92: 1278-1284.
33. op den Dries S, Karimian N, Sutton ME, et al. Ex vivo normothermic machine perfusion and viability testing of discarded human donor livers. Am J Transplant 2013; 13: 1327-1335.
34. Kim DY, Moon J, Island ER, et al. Liver transplantation using elderly donors: A risk factor analysis. Clin Transplant 2011; 25: 270-276.
35. D'Amico F, Vitale A, Gringeri E, et al. Liver transplantation using suboptimal grafts: Impact of donor harvesting technique. Liver Transpl 2007; 13: 1444-1450.
36. Heidenhain C, Pratschke J, Puhl G, et al. Incidence of and risk factors for ischemic type biliary lesions following orthotopic liver transplantation. Transpl Int 2010; 23: 14-22.
37. Gurusamy KS, Naik P, Abu-Amara M, Fuller B, Davidson BR., Techniques of flushing and reperfusion for liver transplantation. Cochrane Database Syst Rev 2012; 3.
38. Mutimer DJ, Gunson B, Chen J, et al. Impact of donor age and year of transplantation on graft and patient survival following liver transplantation for hepatitis C virus. Transplantation 2006; 81: 7-14.
39. De Simone P, Metselaar HJ, Fischer L, et al. Conversion from a calcineurin inhibitor to everolimus therapy in maintenance liver transplant recipients: A prospective, randomized, multicenter trial. Liver Transpl 2009; 15: 1262-1269.
40. Basta G, Navarra T, De Simone P, Del Turco S, Gastaldelli A, Filipponi F., What is the role of the receptor for advanced glycation end products-ligand axis in liver injury ? Liver Transpl 2011; 17: 633-640.
41. Ghinolfi D, De Simone P, Catalano G, et al. Transjugular intrahepatic portosystemic shunt for hepatitis C virus-related portal hypertension after liver transplantation. Clin Transplant 2012; 26: 699-705.
42. De Geest S, Dobbels F, Gordon E, De Simone P., Chronic illness management as an innovative pathway for enhancing long-term survival in transplantation. Am J Transplant 2011; 11: 2262-2263.
43. Halldorson JB, Bakthavatsalam R, Fix O, Reyes JD, Perkins JD., D-MELD, a simple predictor of post liver transplant mortality for optimization of donor/recipient matching. Am J Transplant 2009; 9: 318-326.